have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once-daily dosing, and all are more effective when ...

Researchers found that over-use of short acting reliever drugs known as beta agonists is associated with a higher risk of death from asthma. But regular use of inhaled steroids, known as longer ...

Asthma management in winter can be a challenge, but with the right tools, your symptoms will be better controlled. By getting ...

Five patents related to Teva Pharmaceutical Industries Ltd.’s ProAir HFA asthma inhaler don’t cover the treatment’s active ingredient and must be delisted from the US Food and Drug Administration’s ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

Eosinophils are implicated in about half of asthma attacks and ... cannot be controlled with regular inhalers then doctors currently prescribe a course of steroids. The study, on 158 people ...

Flovent, a corticosteroid treatment now sold under its generic name fluticasone propionate, was one of the most commonly prescribed pediatric asthma treatments, in particular because the inhaler ...

A University of Arizona Health Sciences-led program that provides schools with asthma inhalers to help students experiencing ...